1. Home
  2. BDRX

as 06-27-2025 9:30am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Founded: 2000 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 5.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 3.2M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -14.48 EPS Growth: N/A
52 Week Low/High: $0.78 - $41.50 Next Earning Date: 04-11-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

BDRX Daily Stock ML Predictions

Share on Social Networks: